Clasp Therapeutics

Developer of T cell therapeutics for the treatment of cancer

placeRockville, Maryland, United States calendar_todayFounded 2020 language clasptx.com

Social engagement

Social engagement: 6.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Catalio Capital Management, Third Rock Ventures, Novo Holdings.

Investor typeCountShare
Venture capital333%
Private equity111%
Other / undisclosed556%

Recent activity

27 May 2026
Recognition
Coming soon